Search

Author/Creator Galardi, Francesca

1. Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients. Issue 4 (9th December 2014)

Authors:
Pestrin, Marta; Salvianti, Francesca; Galardi, Francesca; De Luca, Francesca; Turner, Natalie; Malorni, Luca; Pazzagli, Mario; Di Leo, Angelo; Pinzani, Pamela
Journal:
Molecular oncology
Issue:
Volume 9:Issue 4(2015:Apr.)
Page Start:
749
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor–positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT). (June 2019)

Authors:
McCartney, Amelia; Biagioni, Chiara; Schiavon, Gaia; Bergqvist, Mattias; Mattsson, Karin; Migliaccio, Ilenia; Benelli, Matteo; Romagnoli, Dario; Bonechi, Martina; Boccalini, Giulia; Pestrin, Marta; Galardi, Francesca; De Luca, Francesca; Biganzoli, Laura; Piccart, Martine; Gradishar, William J.; ...
Journal:
European journal of cancer
Issue:
Volume 114(2019)
Page Start:
55
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. The challenge of sustainability in healthcare systems: economic and organizational impact of subcutaneous formulations for rituximab and trastuzumab in onco-hematology. (4th May 2021)

Authors:
Altini, Mattia; Gentili, Nicola; Balzi, William; Musuraca, Gerado; Maltoni, Roberta; Masini, Carla; Galardi, Francesca; Bertoni, Lucia; Massa, Ilaria
Journal:
Expert review of pharmacoeconomics & outcomes research
Issue:
Volume 21:Number 3(2021)
Page Start:
503
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. TOP2A protein by quantitative immunofluorescence as a predictor of response to epirubicin in the neoadjuvant treatment of breast cancer. (October 2013)

Authors:
Moretti, Erica; Desmedt, Christine; Biagioni, Chiara; Regan, Meredith M; Oakman, Catherine; Larsimont, Denis; Galardi, Francesca; Piccart-Gebhart, Martine; Sotiriou, Christos; Rimm, David L; Di Leo, Angelo
Journal:
Future oncology
Issue:
Volume 9:Number 10(2013)
Page Start:
1477
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. TOP2A protein by quantitative immunofluorescence as a predictor of response to epirubicin in the neoadjuvant treatment of breast cancer. (October 2013)

Authors:
Moretti, Erica; Desmedt, Christine; Biagioni, Chiara; Regan, Meredith M; Oakman, Catherine; Larsimont, Denis; Galardi, Francesca; Piccart-Gebhart, Martine; Sotiriou, Christos; Rimm, David L; Di Leo, Angelo
Journal:
Future oncology
Issue:
Volume 9:Number 10(2013)
Page Start:
1477
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗